loadpatents
name:-0.018365859985352
name:-0.012560844421387
name:-0.0064380168914795
Dutt; Chaitanya Patent Filings

Dutt; Chaitanya

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dutt; Chaitanya.The latest application filed is for "novel pyridinium compounds".

Company Profile
6.12.14
  • Dutt; Chaitanya - Gandhinagar IN
  • Dutt; Chaitanya - Gujrat IN
  • Dutt; Chaitanya - Gujarat IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical formulations
Grant 10,772,879 - Dutt , et al. Sept
2020-09-15
Pyridinium compounds
Grant 10,717,727 - Dutt , et al.
2020-07-21
Low dose pharmaceutical composition
Grant 10,471,005 - Dutt , et al. Nov
2019-11-12
Novel Pyridinium Compounds
App 20190169175 - DUTT; Chaitanya ;   et al.
2019-06-06
Substituted Fused Pyrimidinone Compounds
App 20190127381 - DUTT; Chaitanya ;   et al.
2019-05-02
Pyridinium compounds
Grant 10,233,175 - Dutt , et al.
2019-03-19
Fused imidazobenzothiazole compounds
Grant 10,227,361 - Shinde , et al.
2019-03-12
Novel Fused Imidazobenzothiazole Compounds
App 20180127437 - SHINDE; Pundlik ;   et al.
2018-05-10
Urea-substituted indanes as P38 map kinase inhibitors
Grant 9,963,463 - Rode , et al. May 8, 2
2018-05-08
Novel Pyridinium Compounds
App 20180118728 - DUTT; Chaitanya ;   et al.
2018-05-03
Pharmaceutical Formulations
App 20180110763 - DUTT; Chaitanya ;   et al.
2018-04-26
Fused imidazobenzothiazole compounds
Grant 9,908,898 - Shinde , et al. March 6, 2
2018-03-06
P38 Map Kinase Inhibiting Indanyl Urea Compounds
App 20170247390 - RODE; Milind ;   et al.
2017-08-31
Low Dose Pharmaceutical Composition
App 20170157129 - DUTT; Chaitanya ;   et al.
2017-06-08
Novel Fused Imidazobenzothiazole Compounds
App 20170107233 - SHINDE; Pundlik ;   et al.
2017-04-20
Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
Grant 9,610,247 - Dutt , et al. April 4, 2
2017-04-04
Use Of A Thiazolo Pyrimidinone For The Treatment Of Inflammatory Bowel Disease
App 20160120801 - DUTT; Chaitanya ;   et al.
2016-05-05
Novel Substituted Imidazopyrimidines as Gpbar1 Receptor Modulators
App 20150126530 - Dutt; Chaitanya ;   et al.
2015-05-07
Fused thiazolo and oxazolo pyrimidinones
Grant 8,822,484 - Srivastava , et al. September 2, 2
2014-09-02
Novel Fused Thiazolo And Oxazolo Pyrimidinones
App 20130331406 - SRIVASTAVA; Sanjay ;   et al.
2013-12-12
Fused thiazolo and oxazolo pyrimidinones
Grant 8,541,430 - Srivastava , et al. September 24, 2
2013-09-24
Thyroid like compounds
Grant 8,143,424 - Chhipa , et al. March 27, 2
2012-03-27
Novel Heterocyclic Compounds
App 20120046317 - Dutt; Chaitanya ;   et al.
2012-02-23
Novel Fused Thiazolo And Oxazolo Pyrimidinones
App 20110130414 - Srivastava; Sanjay ;   et al.
2011-06-02
Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
App 20110034378 - Dutt; Chaitanya ;   et al.
2011-02-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed